Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mechanisms involved in somatostatin receptor regulation in corticotroph tumors: the role of cytoskeleton and USP8 mutations. | Endocr Oncol | 2022 | 37435448 | PubTator, text mining | PubMed |
| Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma. | Dis Markers | 2022 | 37223105 | PubTator, text mining | PubMed |
| Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors: Clinicopathological Analysis of 223 Cases and Whole Exome Sequencing of a Multifocal Case. | Pancreas | 2022 | 37099786 | PubTator, text mining | PubMed |
| Why Glucagon Matters for Hypoglycemia and Physical Activity in Individuals With Type 1 Diabetes. | Front Clin Diabetes Healthc | 2022 | 36992764 | PubTator, text mining | PubMed |
| Identification of key biomarkers and signaling pathways and analysis of their association with immune cells in immunoglobulin A nephropathy. | Cent Eur J Immunol | 2022 | 36817268 | PubTator, text mining | PubMed |
| Ga-68 DOTATATE PET/CT in the Evaluation of Paragangliomas and Other Indeterminate Lesions in the Head and Neck. | Indian J Nucl Med | 2022 | 36817195 | PubTator, text mining | PubMed |
| Standardized classification schemes in reporting oncologic PET/CT. | Front Med (Lausanne) | 2022 | 36777163 | PubTator, text mining | PubMed |
| Case report: NUT carcinoma with MXI1::NUTM1 fusion characterized by abdominopelvic lesions and ovarian masses in a middle-aged female. | Front Oncol | 2022 | 36741693 | PubTator, text mining | PubMed |
| Case Report: Octreotide plus CVD chemotherapy for the treatment of multiple metastatic paragangliomas after double resection for functional bladder paraganglioma and urothelial papilloma. | Front Oncol | 2022 | 36741690 | PubTator, text mining | PubMed |
| Case report: Concurrent malignant triton tumor and relapsed pituitary adenoma in the sellar region. | Front Surg | 2022 | 36713674 | PubTator, text mining | PubMed |
| [Short-term and long-term remission after endoscopic transnasal adenomectomy in patients with acromegaly]. | Probl Endokrinol (Mosk) | 2022 | 36689713 | PubTator, text mining | PubMed |
| Astatine-211 based radionuclide therapy: Current clinical trial landscape. | Front Med (Lausanne) | 2022 | 36687417 | PubTator, text mining | PubMed |
| Asymptomatic Intraosseous Meningioma of the Humerus: A Case Report and Review of the Literature. | Cureus | 2022 | 36654535 | PubTator, text mining | PubMed |
| Pulmonary Function Tests as a Biomarker in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia Patients Treated With Somatostatin Analogues. | Cureus | 2022 | 36644074 | PubTator, text mining | PubMed |
| Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study. | J Clin Med | 2022 | 36614826 | PubTator, text mining | PubMed |
| Recent Advances in Cardiovascular Diseases Research Using Animal Models and PET Radioisotope Tracers. | Int J Mol Sci | 2022 | 36613797 | PubTator, text mining | PubMed |
| Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines. | Cancers (Basel) | 2022 | 36612291 | PubTator, text mining | PubMed |
| The Prognostic-Based Approach in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors (PitNET): Tertiary Reference Center, Single Senior Surgeon, and Long-Term Follow-Up. | Cancers (Basel) | 2022 | 36612263 | PubTator, text mining | PubMed |
| Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells. | Cancers (Basel) | 2022 | 36612109 | PubTator, text mining | PubMed |
| Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer. | Cancers (Basel) | 2022 | 36612012 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=39